Clinical and prognostic significance of urinary trypsin inhibitor in patients with hepatocellular carcinoma after hepatectomy

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2805-2817

  Kikuchi, Isao ^a   Uchinami, Hiroshi ^a   Nanjo, Hiroshi ^a   Hashimoto, Manabu ^a   Nakajima, Akio ^b   Kume, Makoto ^a   Mencin, Ali ^c   Yamamoto, Yuzo ^a,b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; PROTHROMBIN; ULINASTATIN; GLYCOPROTEIN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BLOOD TRANSFUSION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMIHEPATECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER LEVEL; LIVER METASTASIS; LIVER RESECTION; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRECANCER; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; TUMOR RECURRENCE; TUMOR VOLUME; BLOOD; CANCER INVASION; CANCER STAGING; COHORT ANALYSIS; ENZYME IMMUNOASSAY; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; GLYCOPROTEINS; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 73349125798     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0622-2     Document Type: Article

References (34)

1. Benzoni E, Cojutti A, Lorenzin D, et al. Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg. 2007;392:45-54.
2. Zhou L, Rui JA, Wang SB, et al. Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg. 2007;31:1782-7.
3. Shimada M, Takenaka K, Fujiwara Y, et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carci-noma. Br J Surg. 1998;85:195-8.
4. Shulman NR. A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. J Biol Chem. 1955; 213:655-71.
5. Hirose J, Ozawa T, Miura T, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull. 1998;21:651-6.
6. Sato N, Endo S, Kimura Y, et al. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg. 2002;19:300-5.
7. Uemura K, Murakami Y, Hayashidani Y, et al. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. J Surg Oncol. 2008;98:309-13.
8. Ambiru S, Miyazaki M, Sasada K, et al. Effects of perioperative protease inhibitor on inflammatory cytokines and acute-phase proteins in patients with hepatic resection. Dig Surg. 2000; 17:337-43.
9. Kobayashi H, Suzuki M, Kanayama N, et al. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade. Eur J Biochem. 2002;269:3945-57.
10. Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade. J Biol Chem. 2003;278:7790-9.
11. Yamamoto Y, Ikai I, Kume M, et al. New simple technique for hepatic parenchymal resection using a Cavitron Ultrasonic Surgical Aspirator and bipolar cautery equipped with a channel for water dripping. World J Surg. 1999;23:1032-7
12. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd English ed. Tokyo: Kanehara, 2003.
13. Lin SD, Endo R, Sato A, et al. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis. J Gastroenterol Hepatol. 2002;17:140-7.
14. Jonsson-Berling BM, Ohlsson K, Rosengren M. Radioimmu-nological quantitation of the urinary trypsin inhibitor in normal blood and urine. Biol Chem Hoppe Seyler. 1989; 370:1157-61.
15. Uchinami H, Seki E, Brenner DA, D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during chole-stasis. Hepatology. 2006;44:420-9.
16. Tanaka Y, Kobayashi H, Suzuki M, et al. Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma. Cancer. 2003;98:424-30.
17. Noie T, Sugawara Y, Harihara Y, et al. Kinetics of urinary trypsin inhibitor in patients undergoing partial hepatectomy. Scand J Gastroenterol. 2001;36:410-6.
18. Yamamoto Y. Liver resection in liver cirrhosis. Chirurg. 2001;72:784-93.
19. Taura K, Ikai I, Hatano E, et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of610 patients over 16 years old. Ann Surg. 2006;244:265-73.
20. Yoshida E, Sumi H, Maruyama M, et al. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malig-nant human tissues. Cancer. 1989;64:860-9.
21. Tanaka Y, Kobayashi H, Suzuki M, et al. Upregulation of bikunin in tumor-infiltrating macrophages as a factor of favorable prog-nosis in ovarian cancer. Gynecol Oncol. 2004;94:725-34.
22. Bourguignon J, Borghi H, Sesboue R, et al. Immunohistochem-ical distribution of inter-alpha-trypsin inhibitor chains in normal and malignant human lung tissue. J Histochem Cytochem. 1999;47:1625-32.
23. Ogasawara S, Yano H, Momosaki S, et al. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues. Oncol Rep. 2005;13:1043-8.
24. Yoshioka I, Tsuchiya Y, Aozuka Y, et al. Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells. Anticancer Res. 2005;25:815-20.
25. Tsui KH, Chang PL, Feng TH, et al. Down-regulation of ma-triptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Res. 2008;28:1977-83.
26. Grondahl-Hansen J, Christensen IJ, Rosenquist C, et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 1993;53:2513-21.
27. Pappot H, Pedersen AN, Brunner N, Christensen IJ. The complex between urokinase (uPA) and its type-1 inhibitor (PAI-1) in pulmonary adenocarcinoma: relation to prognosis. Lung Cancer. 2006;51:193-200.
28. Tonouchi A, Ohtsuka M, Ito H, et al. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection. Am J Gastroenterol. 2006;101:1601-10.
29. Lee YC, Pan HW, Peng SY, et al. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer. 2007;43:736-44.
30. Paju A, Vartiainen J, Haglund C, et al. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovar-ian cancer: prognostic study on tissue and serum. Clin Cancer Res. 2004;10:4761-8.
31. Wiksten JP, Lundin J, Nordling S, et al. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology. 2005;46:380-8.
32. McKeehan WL, Sakagami Y, Hoshi H, McKeehan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem. 1986;261:5378-83.
33. Perry JK, Scott GK, Tse CA. Modulation of proliferation of cultured human cells by urinary trypsin inhibitor. Biochim Bio-phys Acta. 1994;1221:145-52.
34. Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novel protease inhibitor and neutral protease activator. Transplant Proc 2008;40:387-9.